CO5750041A1 - Metodo para la fabricacion de un medicamento a base de una mezcla de acidos grasos poliinsaturados para la prevencion de infecciones respiratorias en infantes - Google Patents
Metodo para la fabricacion de un medicamento a base de una mezcla de acidos grasos poliinsaturados para la prevencion de infecciones respiratorias en infantesInfo
- Publication number
- CO5750041A1 CO5750041A1 CO05094613A CO05094613A CO5750041A1 CO 5750041 A1 CO5750041 A1 CO 5750041A1 CO 05094613 A CO05094613 A CO 05094613A CO 05094613 A CO05094613 A CO 05094613A CO 5750041 A1 CO5750041 A1 CO 5750041A1
- Authority
- CO
- Colombia
- Prior art keywords
- prevention
- infants
- manufacture
- mixture
- fatty acids
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 206010057190 Respiratory tract infections Diseases 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 235000014113 dietary fatty acids Nutrition 0.000 title 1
- 229930195729 fatty acid Natural products 0.000 title 1
- 239000000194 fatty acid Substances 0.000 title 1
- 150000004665 fatty acids Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000037396 body weight Effects 0.000 abstract 4
- 206010006448 Bronchiolitis Diseases 0.000 abstract 1
- 206010011416 Croup infectious Diseases 0.000 abstract 1
- 206010035664 Pneumonia Diseases 0.000 abstract 1
- 241000725643 Respiratory syncytial virus Species 0.000 abstract 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 abstract 1
- 206010006451 bronchitis Diseases 0.000 abstract 1
- 201000010549 croup Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 206010022000 influenza Diseases 0.000 abstract 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pediatric Medicine (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66911105P | 2005-04-07 | 2005-04-07 | |
| US11/114,892 US20060229366A1 (en) | 2005-04-07 | 2005-04-26 | Method for preventing or treating respiratory infections in infants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5750041A1 true CO5750041A1 (es) | 2007-04-30 |
Family
ID=35432875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO05094613A CO5750041A1 (es) | 2005-04-07 | 2005-09-19 | Metodo para la fabricacion de un medicamento a base de una mezcla de acidos grasos poliinsaturados para la prevencion de infecciones respiratorias en infantes |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20060229366A1 (en:Method) |
| EP (1) | EP1709961A1 (en:Method) |
| KR (1) | KR20060106583A (en:Method) |
| AR (1) | AR052641A1 (en:Method) |
| BR (1) | BRPI0503827A (en:Method) |
| CA (1) | CA2516873A1 (en:Method) |
| CO (1) | CO5750041A1 (en:Method) |
| IN (1) | IN2006CH00621A (en:Method) |
| MX (1) | MXPA05009927A (en:Method) |
| NO (1) | NO20055079L (en:Method) |
| PA (1) | PA8649001A1 (en:Method) |
| RU (1) | RU2005130292A (en:Method) |
| SG (1) | SG126810A1 (en:Method) |
| TW (1) | TW200635574A (en:Method) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8343753B2 (en) | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
| WO2009057121A1 (en) * | 2007-11-01 | 2009-05-07 | Enzymotec Ltd. | Lipid mixture for infant nutrition |
| US20130203715A1 (en) * | 2010-07-20 | 2013-08-08 | Pulmatrix, Inc. | Use of trp channel agonists to treat infections |
| WO2012044736A1 (en) | 2010-09-29 | 2012-04-05 | Pulmatrix, Inc. | Monovalent metal cation dry powders for inhalation |
| KR20150135328A (ko) | 2013-04-01 | 2015-12-02 | 풀매트릭스 인코퍼레이티드 | 티오트로피움 건조 분말 |
| WO2022226311A1 (en) * | 2021-04-23 | 2022-10-27 | Abbott Laboratories | Nutritional compositions comprising human milk oligosaccharides and a designed lipid component for improving lung function |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5407957A (en) | 1990-02-13 | 1995-04-18 | Martek Corporation | Production of docosahexaenoic acid by dinoflagellates |
| ATE200619T1 (de) | 1991-01-24 | 2001-05-15 | Martek Corp | Mikrobielle öle und ihre verwendungen |
| MY118354A (en) * | 1995-05-01 | 2004-10-30 | Scarista Ltd | 1,3-propane diol derivatives as bioactive compounds |
| CN1660065A (zh) * | 1997-03-27 | 2005-08-31 | 布里斯托尔-迈尔斯斯奎布公司 | 二十二碳六烯酸和花生四烯酸促进不足月婴儿生长的用途 |
| US6180671B1 (en) * | 1998-03-10 | 2001-01-30 | Beth Israel Deaconess Medical Center, Inc. | Methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected |
| US20040143013A1 (en) * | 2000-02-28 | 2004-07-22 | Bristol-Myers Squibb Company | Use of docosahexaenoic acid and arachidonic acid enhancing the growth of preterm infants |
| DE602004006258T3 (de) * | 2004-08-24 | 2013-08-29 | Nutricia N.V. | Nahrungszusammensetzung die unverdauliche Transgalaktooligosaccharide sowie verdauliche Galaktose-Saccharide enthält |
-
2005
- 2005-04-26 US US11/114,892 patent/US20060229366A1/en not_active Abandoned
- 2005-08-16 TW TW094127898A patent/TW200635574A/zh unknown
- 2005-08-19 CA CA002516873A patent/CA2516873A1/en not_active Abandoned
- 2005-08-23 SG SG200505337A patent/SG126810A1/en unknown
- 2005-08-26 KR KR1020050078917A patent/KR20060106583A/ko not_active Withdrawn
- 2005-08-29 AR ARP050103604A patent/AR052641A1/es unknown
- 2005-09-12 EP EP05255578A patent/EP1709961A1/en not_active Withdrawn
- 2005-09-15 MX MXPA05009927 patent/MXPA05009927A/es not_active Application Discontinuation
- 2005-09-15 BR BRPI0503827-8A patent/BRPI0503827A/pt not_active Application Discontinuation
- 2005-09-19 CO CO05094613A patent/CO5750041A1/es not_active Application Discontinuation
- 2005-09-28 RU RU2005130292/14A patent/RU2005130292A/ru not_active Application Discontinuation
- 2005-10-07 PA PA20058649001A patent/PA8649001A1/es unknown
- 2005-10-31 NO NO20055079A patent/NO20055079L/no not_active Application Discontinuation
-
2006
- 2006-04-04 IN IN621CH2006 patent/IN2006CH00621A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IN2006CH00621A (en:Method) | 2007-06-15 |
| NO20055079L (no) | 2006-10-09 |
| KR20060106583A (ko) | 2006-10-12 |
| US20060229366A1 (en) | 2006-10-12 |
| CA2516873A1 (en) | 2006-10-07 |
| SG126810A1 (en) | 2006-11-29 |
| TW200635574A (en) | 2006-10-16 |
| MXPA05009927A (es) | 2006-10-01 |
| AR052641A1 (es) | 2007-03-28 |
| PA8649001A1 (es) | 2006-10-13 |
| BRPI0503827A (pt) | 2006-12-19 |
| RU2005130292A (ru) | 2007-04-10 |
| NO20055079D0 (no) | 2005-10-31 |
| EP1709961A1 (en) | 2006-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124720T1 (el) | Απο του στοματος σκευασματα αναλογων κυτιδινης και μεθοδοι χρησης αυτων | |
| ATE429416T1 (de) | Cyanophenoxy-carbonsäuren und zusammensetzungen für die freisetzung aktiver substanzen | |
| MX2010001839A (es) | Metodo y aparato para comunicacion y metodo y aparato para controlar comunicacion. | |
| UY39192A (es) | Dispersión sólida, proceso para prepararla y forma de dosificación farmacéutica suministrable por vía oral que la comprende | |
| BR112013022044A2 (pt) | veículo mastigável para absorção na boca | |
| HN2001000037A (es) | Derivados de eteres de pirazol como agentes antiinflamatorios/analgesicos | |
| GT200600445A (es) | Formas de presentación farmaceuticas solidas de administración oral con liberacion rapida del principio activo. | |
| ES2916604T1 (es) | Ensayos de detección de nrf2 y métodos y composiciones relacionados | |
| HRP20160605T1 (hr) | Tetraciklički spoj | |
| MX2012007410A (es) | Compuestos antivirales novedosos. | |
| BR0210261A (pt) | Formulações farmacêuticas para a administração eficiente de apomorfina, 6ar-(-)-n-propil-norapomorfina e seus derivados e pró-drogas destes | |
| UY29377A1 (es) | Nuevas formilaciones líquidas de rotavirus, su preparación y sus usos. | |
| MX354423B (es) | Formulaciones de rasagilina de liberación prolongada y usos de las mismas. | |
| BR122019027412B8 (pt) | composição farmacêutica de liberação sustentada na forma de micropartículas, processo para preparação das ditas micropartículas, e kit de administração | |
| AR077138A1 (es) | Composiciones farmaceuticas utiles para tratar el vhc | |
| WO2006029081A3 (en) | Nucleoside-lipid conjugates, their method of preparation and uses thereof | |
| BRPI0410044A (pt) | forma de dosagem contendo pantoprazol como ingrediente ativo | |
| CO5750041A1 (es) | Metodo para la fabricacion de un medicamento a base de una mezcla de acidos grasos poliinsaturados para la prevencion de infecciones respiratorias en infantes | |
| CO6640318A2 (es) | Formas de dosificación oral de bendamustina | |
| GT200800235A (es) | Formulacion de medicamento liquida | |
| PE20061314A1 (es) | Asociacion entre la ferroquina y un derivado de artemisinina para el tratamiento del paludismo | |
| JP2015522040A5 (en:Method) | ||
| ECSP003508A (es) | Formas polimorfas de un citrato de azobiciclo [2.2.2] octan-3-amina y sus composiciones farmaceuticas | |
| AR046464A1 (es) | Multiparticulas de liberacion controlada con mejoradores de la disolucion | |
| MD3121G2 (ro) | Metodă de profilaxie a hepatitei virale B |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Application withdrawn |